FX Shoulder USA, Inc. to Begin Clinical Study on Stemless Reversed Total Shoulder
DALLAS, December 5, 2018 /PRNewswire/ -- FX Shoulder USA, Inc. will begin in December 2018 the FDA approved Investigational Device Exemption (IDE) clinical study of the Easytech Reversed stemless, a shoulder prosthesis, with its first implantation scheduled for December. Easytech Reversed Stemless is an innovative shoulder arthroplasty implant that will be under clinical study with (9) sites and (12) surgeons